5.01 USD
▲+0.03+0.60%
盘后 4.99 +0.20%
2026-08-03
市值
$1.24B
市盈率
—
EPS
-0.24
股息率
—
52 周区间
4.24 – 8.40
成交量
3.13M
Beta
0.60
目标价
16.30
52W 低 4.2452W 高 8.40
价格走势
公司简介
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 an...